Global Ureteral Stent Market Size (2024 - 2029)

The ureteral stent market is anticipated to experience growth over the forecast period, driven by increased awareness, research and development, and government-funded programs. The COVID-19 pandemic significantly impacted the market due to its effects on healthcare and the increased risk of kidney-related issues among patients. Despite these growth drivers, the market faces challenges, such as the risk of infection, which may restrain its expansion.

Market Size of Global Ureteral Stent Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Ureteral Stent Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.10 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Ureteral Stent Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Ureteral Stents Market Analysis

The ureteral stent market is expected to record a CAGR of 6.1% over the forecast period (2022-2027).

COVID-19 had a notable impact on the overall healthcare industry. As per the article published in 2020 under the title 'Urinary stone management during the COVID-19 pandemic: a suggested approach and review of literature', the study suggested that at-risk patients should be evaluated for urinary stones with ultrasonography after the lockdown period. The prolonged homestay has several negative effects on patients, including weight gain and physical inactivity, which may increase their chance of developing kidney stones. Furthermore, the article published in 2021 under the title 'Challenges in Urology during the COVID-19 Pandemic', stated that the issue of renal injury in COVID-19 patients needs a lot of attention since the chance of fluctuations in blood components is likely to be higher compared to other patients. Hence as per the factors mentioned above, COVID-19 had a significant impact on the ureteral stent market.

According to the American Urological Association, the most prevalent urological conditions are benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), and ureteral stones. As per the same source, the average number of practicing urologists in the United States was 13,790 in 2021. Increased awareness, research and development, and government-funded programs related to the studies field boost market growth. For instance, the National Institute of Diabetes and Digestive and Kidney Diseases celebrated national kidney month in March 2022. The source states that NIDDK raises awareness and focuses on building paths to better kidney care.

As per the aforementioned factors, the ureteral stent market is likely to grow over the forecast period. However, the risk of infection restrains the market growth.

Ureteral Stents Industry Segmentation

As per the scope of the report, ureteral stents are tubes that are usually placed in the ureter to prevent blockage and allow passage for urine flow from the kidney to the urinary bladder. The Ureteral Stent Market is segmented by Product Type (Open-Ended, Close Ended, Double Pigtail, and Multiloop), Application (Kidney Stones, Kidney Transplant, Urinary Tract Infection, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Product Type
Open-Ended
Close-Ended
Double Pigtail
Multiloop
By Application
Kidney Stones
Kidney Transplant
Urinary Tract Infection
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Need A Different Region Or Segment?
Customize Now

Global Ureteral Stent Market Size Summary

The ureteral stent market is poised for growth, driven by increasing awareness and advancements in urological health. The market is influenced by the prevalence of conditions such as benign prostatic hyperplasia, urinary tract infections, and ureteral stones, which are common in the United States. The impact of COVID-19 has been significant, with studies highlighting the need for careful management of urinary stones and renal injuries in affected patients. Government initiatives and research efforts, such as those by the National Institute of Diabetes and Digestive and Kidney Diseases, are enhancing awareness and improving kidney care, further propelling market expansion. Despite the potential for growth, the market faces challenges, including the risk of infection associated with ureteral stents.

North America is expected to dominate the global ureteral stent market, largely due to the rising incidence of kidney-related diseases and chronic conditions like diabetes and high blood pressure. The region benefits from substantial research and development efforts, focusing on innovative stent designs that minimize tissue irritation and microbial adherence. Strategic initiatives by key players, including collaborations and product innovations, are also contributing to market growth. Companies such as Boston Scientific and Olympus Corporation are leading the way with advancements like the Tria Ureteral Stent, which offers enhanced protection against mineral deposits. These factors collectively suggest a positive outlook for the ureteral stent market over the forecast period.

Explore More

Global Ureteral Stent Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Burden of Urological Disorders

      2. 1.2.2 Awarness Campaigns Initiated by Government and Other Organization

    3. 1.3 Market Restraints

      1. 1.3.1 Risk of Infection

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product Type

      1. 2.1.1 Open-Ended

      2. 2.1.2 Close-Ended

      3. 2.1.3 Double Pigtail

      4. 2.1.4 Multiloop

    2. 2.2 By Application

      1. 2.2.1 Kidney Stones

      2. 2.2.2 Kidney Transplant

      3. 2.2.3 Urinary Tract Infection

      4. 2.2.4 Other Applications

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Rest of the World

Global Ureteral Stent Market Size FAQs

The Global Ureteral Stent Market is projected to register a CAGR of 6.10% during the forecast period (2024-2029)

Boston Scientific, Teleflex Inc., Beckton, Dickinson and Company, B. Braun SE and Olympus Corporation are the major companies operating in the Global Ureteral Stent Market.

Ureteral Stents Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)